Augmentation of Therapeutic Angiogenesis Using Genetically Modified Human Endothelial Progenitor Cells with Altered Glycogen Synthase Kinase-3β Activity
Jin‐Ho Choi(Qurient (South Korea)), Hyo-Soo Kim(Seoul National University Hospital)
Cited by 96
Related Papers
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis
|Journal of the American College of Cardiology|2017|473
Catastrophic health expenditure on acute coronary events in Asia: a prospective study
|Bulletin of the World Health Organization|2016|54
KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state
|Journal of Hematology & Oncology|2021|49